<p>Privia Health Group, Inc. (NASDAQ:PRVA - 获取免费报告) 的股价在周四的交易中创下了新的 52 周高点。该股最高交易价格为 26.51 美元，最后交易价格为 26.02 美元，交易量为 83139 股。该股此前收盘价为 25.02 美元。</p>
<p>获取 <strong>Privia Health Group</strong> 的提醒：</p>
<h2>分析师评级变动</h2>
<p>PRVA 最近受到多份分析师报告的关注。巴克莱将 Privia Health Group 的目标价从 21.00 美元上调至 22.00 美元，并在 10 月 9 日的研究报告中给予该股 “持平” 评级。Zacks Research 在 8 月 19 日的研究报告中将 Privia Health Group 的评级从 “强烈卖出” 上调至 “持有”。花旗在 8 月 29 日的研究报告中重申了对 Privia Health Group 股票的 “跑赢大盘” 评级。Evercore ISI 在 7 月 9 日的研究报告中将 Privia Health Group 的目标价从 30.00 美元下调至 28.00 美元，并给予该公司 “跑赢大盘” 评级。最后，Piper Sandler 在 8 月 11 日的报告中将 Privia Health Group 的目标价从 36.00 美元下调至 35.00 美元，并对该股给予 “增持” 评级。共有 11 位研究分析师对该股给予 “买入” 评级，2 位给予 “持有” 评级，1 位给予 “卖出” 评级。根据 MarketBeat.com 的数据，该公司的共识评级为 “适度买入”，共识目标价为 28.91 美元。</p>
<p><strong>阅读我们对 PRVA 的最新分析</strong></p>
<h2>Privia Health Group 股票表现</h2>
<p>该股的 50 日移动平均线为 24.10 美元，200 日移动平均线为 22.76 美元。该公司的市值为 31.8 亿美元，市盈率为 236.70，PEG 比率为 3.37，贝塔值为 0.83。</p>
<p>Privia Health Group (NASDAQ:PRVA - 获取免费报告) 最近于 6 月 7 日发布了其财报。该公司报告季度每股收益（EPS）为 0.10 美元。该季度的收入为 2.1361 亿美元。Privia Health Group 的股本回报率为 2.13%，净利润率为 0.78%。研究分析师平均预计 Privia Health Group, Inc.在当前年度将发布 0.14 美元的每股收益。</p>
<h2>机构投资者对 Privia Health Group 的看法</h2>
<p>几家对冲基金最近买入和卖出了该股的股份。Smartleaf Asset Management LLC 在第三季度将其在 Privia Health Group 的持股增加了 37.4%。Smartleaf Asset Management LLC 目前拥有该公司价值 303,000 美元的 12,398 股股票，在上个季度额外购买了 3,373 股。Van Berkom &amp; Associates Inc.在第三季度将其在 Privia Health Group 的持股增加了 30.1%。Van Berkom &amp; Associates Inc.目前拥有该公司价值 93,987,000 美元的 3,774,565 股股票，在此期间额外购买了 873,344 股。Thrivent Financial for Lutherans 在第三季度将其在 Privia Health Group 的持股增加了 8.0%。Thrivent Financial for Lutherans 目前拥有该公司价值 2,072,000 美元的 83,229 股股票，在此期间额外购买了 6,130 股。亚利桑那州退休系统在第三季度将其在 Privia Health Group 的持股增加了 1.9%。亚利桑那州退休系统目前拥有该公司价值 718,000 美元的 28,835 股股票，在上个季度额外购买了 524 股。最后，Summit Global Investments 在第三季度将其在 Privia Health Group 的持股增加了 273.9%。Summit Global Investments 目前拥有该公司价值 839,000 美元的 33,677 股股票，在上个季度额外购买了 24,670 股。94.48% 的股票目前由机构投资者和对冲基金持有。</p>
<h2>关于 Privia Health Group</h2>
<p>(获取免费报告)</p>
<p>Privia Health Group, Inc. 是一家在美国运营的全国性医生赋能公司。该公司与医疗集团、健康计划和健康系统合作，以优化医生的实践，提升患者体验，并奖励医生在面对面和虚拟环境中提供护理。</p>
<h2>另见</h2>
<ul>
<li>我们更看好的五只股票比 Privia Health Group 更好</li>
<li>投资于高市盈率成长股</li>
<li>Dutch Bros 连续第 11 个季度超出预期</li>
<li>股票平均计算器</li>
<li>从分红到增长：为什么这三只股票在 2025 年脱颖而出</li>
<li>股票情绪分析：它是如何工作的</li>
<li>AMD 的价格回调等于机会：大幅收益即将到来</li>
</ul>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在 Privia Health Group 吗？</h2>
<p>在你考虑 Privia Health Group 之前，你需要听听这个。</p>
<p>MarketBeat 跟踪华尔街顶级评级和表现最佳的研究分析师及其每日推荐的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前立即购买……而 Privia Health Group 并不在名单上。</p>
<p>虽然 Privia Health Group 目前在分析师中获得 “适度买入” 评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>查看这五只股票</p>

PRVA

<p>Privia Health Group（纳斯达克代码：PRVA）创下了 52 周的新高，达到 26.51 美元，收盘价为 26.02 美元，交易量为 83,139 股。分析师的评级意见不一，巴克莱将目标价上调至 22.00 美元，扎克斯则将评级上调至 “持有”。该股票的共识评级为 “适度买入”，目标价为 28.91 美元。机构投资者持有该股票的 94.48%。公司报告上个季度每股收益为 0.10 美元，收入为 2.1361 亿美元</p>

<p>Privia Health Group, Inc. (NASDAQ:PRVA - Get Free Report)'s share price hit a new 52-week high during trading on Thursday . The stock traded as high as $26.51 and last traded at $26.02, with a volume of 83139 shares traded. The stock had previously closed at $25.02.</p>
<div class="lb-trans"><p>Privia Health Group, Inc. (NASDAQ:PRVA - 获取免费报告) 的股价在周四的交易中创下了新的 52 周高点。该股最高交易价格为 26.51 美元，最后交易价格为 26.02 美元，交易量为 83139 股。该股此前收盘价为 25.02 美元。</p>
</div><p>Get <strong>Privia Health Group</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>Privia Health Group</strong> 的提醒：</p>
</div><h2>Analyst Ratings Changes</h2>
<div class="lb-trans"><h2>分析师评级变动</h2>
</div><p>PRVA has been the subject of several recent analyst reports. Barclays raised their target price on Privia Health Group from $21.00 to $22.00 and gave the stock an &#34;equal weight&#34; rating in a research report on Thursday, October 9th. Zacks Research raised Privia Health Group from a &#34;strong sell&#34; rating to a &#34;hold&#34; rating in a research report on Tuesday, August 19th. Citigroup reissued an &#34;outperform&#34; rating on shares of Privia Health Group in a research report on Friday, August 29th. Evercore ISI reduced their price objective on Privia Health Group from $30.00 to $28.00 and set an &#34;outperform&#34; rating for the company in a research report on Wednesday, July 9th. Finally, Piper Sandler cut their target price on Privia Health Group from $36.00 to $35.00 and set an &#34;overweight&#34; rating on the stock in a report on Monday, August 11th. Eleven research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the company has a consensus rating of &#34;Moderate Buy&#34; and a consensus target price of $28.91.</p>
<div class="lb-trans"><p>PRVA 最近受到多份分析师报告的关注。巴克莱将 Privia Health Group 的目标价从 21.00 美元上调至 22.00 美元，并在 10 月 9 日的研究报告中给予该股 “持平” 评级。Zacks Research 在 8 月 19 日的研究报告中将 Privia Health Group 的评级从 “强烈卖出” 上调至 “持有”。花旗在 8 月 29 日的研究报告中重申了对 Privia Health Group 股票的 “跑赢大盘” 评级。Evercore ISI 在 7 月 9 日的研究报告中将 Privia Health Group 的目标价从 30.00 美元下调至 28.00 美元，并给予该公司 “跑赢大盘” 评级。最后，Piper Sandler 在 8 月 11 日的报告中将 Privia Health Group 的目标价从 36.00 美元下调至 35.00 美元，并对该股给予 “增持” 评级。共有 11 位研究分析师对该股给予 “买入” 评级，2 位给予 “持有” 评级，1 位给予 “卖出” 评级。根据 MarketBeat.com 的数据，该公司的共识评级为 “适度买入”，共识目标价为 28.91 美元。</p>
</div><p><strong>Read Our Latest Analysis on PRVA</strong></p>
<div class="lb-trans"><p><strong>阅读我们对 PRVA 的最新分析</strong></p>
</div><h2>Privia Health Group Stock Performance</h2>
<div class="lb-trans"><h2>Privia Health Group 股票表现</h2>
</div><p>The stock's 50-day moving average is $24.10 and its 200 day moving average is $22.76. The firm has a market cap of $3.18 billion, a P/E ratio of 236.70, a PEG ratio of 3.37 and a beta of 0.83.</p>
<div class="lb-trans"><p>该股的 50 日移动平均线为 24.10 美元，200 日移动平均线为 22.76 美元。该公司的市值为 31.8 亿美元，市盈率为 236.70，PEG 比率为 3.37，贝塔值为 0.83。</p>
</div><p>Privia Health Group (NASDAQ:PRVA - Get Free Report) last released its earnings results on Tuesday, June 7th. The company reported $0.10 earnings per share (EPS) for the quarter. The firm had revenue of $213.61 million during the quarter. Privia Health Group had a return on equity of 2.13% and a net margin of 0.78%. On average, research analysts anticipate that Privia Health Group, Inc. will post 0.14 EPS for the current year.</p>
<div class="lb-trans"><p>Privia Health Group (NASDAQ:PRVA - 获取免费报告) 最近于 6 月 7 日发布了其财报。该公司报告季度每股收益（EPS）为 0.10 美元。该季度的收入为 2.1361 亿美元。Privia Health Group 的股本回报率为 2.13%，净利润率为 0.78%。研究分析师平均预计 Privia Health Group, Inc.在当前年度将发布 0.14 美元的每股收益。</p>
</div><h2>Institutional Investors Weigh In On Privia Health Group</h2>
<div class="lb-trans"><h2>机构投资者对 Privia Health Group 的看法</h2>
</div><p>Several hedge funds have recently bought and sold shares of the stock. Smartleaf Asset Management LLC increased its stake in Privia Health Group by 37.4% in the third quarter. Smartleaf Asset Management LLC now owns 12,398 shares of the company's stock valued at $303,000 after acquiring an additional 3,373 shares during the last quarter. Van Berkom &amp; Associates Inc. raised its holdings in shares of Privia Health Group by 30.1% during the third quarter. Van Berkom &amp; Associates Inc. now owns 3,774,565 shares of the company's stock valued at $93,987,000 after purchasing an additional 873,344 shares during the period. Thrivent Financial for Lutherans raised its holdings in shares of Privia Health Group by 8.0% during the third quarter. Thrivent Financial for Lutherans now owns 83,229 shares of the company's stock valued at $2,072,000 after purchasing an additional 6,130 shares during the period. Arizona State Retirement System increased its position in shares of Privia Health Group by 1.9% during the third quarter. Arizona State Retirement System now owns 28,835 shares of the company's stock worth $718,000 after acquiring an additional 524 shares in the last quarter. Finally, Summit Global Investments grew its position in Privia Health Group by 273.9% in the 3rd quarter. Summit Global Investments now owns 33,677 shares of the company's stock worth $839,000 after purchasing an additional 24,670 shares in the last quarter. 94.48% of the stock is currently owned by institutional investors and hedge funds.</p>
<div class="lb-trans"><p>几家对冲基金最近买入和卖出了该股的股份。Smartleaf Asset Management LLC 在第三季度将其在 Privia Health Group 的持股增加了 37.4%。Smartleaf Asset Management LLC 目前拥有该公司价值 303,000 美元的 12,398 股股票，在上个季度额外购买了 3,373 股。Van Berkom &amp; Associates Inc.在第三季度将其在 Privia Health Group 的持股增加了 30.1%。Van Berkom &amp; Associates Inc.目前拥有该公司价值 93,987,000 美元的 3,774,565 股股票，在此期间额外购买了 873,344 股。Thrivent Financial for Lutherans 在第三季度将其在 Privia Health Group 的持股增加了 8.0%。Thrivent Financial for Lutherans 目前拥有该公司价值 2,072,000 美元的 83,229 股股票，在此期间额外购买了 6,130 股。亚利桑那州退休系统在第三季度将其在 Privia Health Group 的持股增加了 1.9%。亚利桑那州退休系统目前拥有该公司价值 718,000 美元的 28,835 股股票，在上个季度额外购买了 524 股。最后，Summit Global Investments 在第三季度将其在 Privia Health Group 的持股增加了 273.9%。Summit Global Investments 目前拥有该公司价值 839,000 美元的 33,677 股股票，在上个季度额外购买了 24,670 股。94.48% 的股票目前由机构投资者和对冲基金持有。</p>
</div><h2>About Privia Health Group</h2>
<div class="lb-trans"><h2>关于 Privia Health Group</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>(获取免费报告)</p>
</div><p>Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.</p>
<div class="lb-trans"><p>Privia Health Group, Inc. 是一家在美国运营的全国性医生赋能公司。该公司与医疗集团、健康计划和健康系统合作，以优化医生的实践，提升患者体验，并奖励医生在面对面和虚拟环境中提供护理。</p>
</div><h2>See Also</h2>
<div class="lb-trans"><h2>另见</h2>
</div><ul>
<li>Five stocks we like better than Privia Health Group</li>
<li>Investing in the High PE Growth Stocks</li>
<li>Dutch Bros Beats Earnings for 11th Consecutive Quarter</li>
<li>Stock Average Calculator</li>
<li>From Dividends to Growth: Why These 3 Stocks Stand Out in 2025</li>
<li>Stock Sentiment Analysis: How it Works</li>
<li>AMD’s Price Pullback Equals Opportunity: The Big Gains Are Coming</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票比 Privia Health Group 更好</li>
<li>投资于高市盈率成长股</li>
<li>Dutch Bros 连续第 11 个季度超出预期</li>
<li>股票平均计算器</li>
<li>从分红到增长：为什么这三只股票在 2025 年脱颖而出</li>
<li>股票情绪分析：它是如何工作的</li>
<li>AMD 的价格回调等于机会：大幅收益即将到来</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Privia Health Group Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 Privia Health Group 吗？</h2>
</div><p>Before you consider Privia Health Group, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考虑 Privia Health Group 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Privia Health Group wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 跟踪华尔街顶级评级和表现最佳的研究分析师及其每日推荐的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前立即购买……而 Privia Health Group 并不在名单上。</p>
</div><p>While Privia Health Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Privia Health Group 目前在分析师中获得 “适度买入” 评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>查看这五只股票</p>
</div>

Privia Health Group（NASDAQ:PRVA）创下 12 个月新高——你应该购买吗？